Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
PaperCitations, authors & open-access status
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 3,299 citations, 2010 year and closed oa status.
3,299
Citations
2010
Year
closed
OA Status